Overview

Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer

Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
1. Determine the response rate with this regimen in an anthracycline and taxane resistant cohort of patients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of New Mexico
Treatments:
Capecitabine
Carboplatin
Vinblastine
Vinorelbine